Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 397 participants.
Also called NCT03683030
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 397 participants
- Sponsor
- Registry
-
NCT03683030
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, China, Italy
- Registry status
- Completed
Technical summary
Registry record NCT03683030. Allocation not applicable; no masking; primary purpose treatment. Start 2018-10-22 (actual); primary completion 2022-02-18 (actual). Results posted on 2025-08-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
- Acronym
- STELLAR
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Multi-Electrode RF Balloon Catheter
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct03683030- Content hash
93e4fe03056ff0f01fcbca5942bdb52687313efd73d26403e92bad494f41aad0